OTIF portfolio company Biofidelity was spun out of Base4 Innovation in early 2019 to develop high performance novel molecular assays for the sensitive detection of low-frequency genetic mutations.
Mario Polywka, the recently retired COO of pharma company Evotec, joined Orbit Discovery’s Board of Directors at the beginning of September 2019.
OTIF portfolio company Oxford PV has announced the first in a series of equipment orders from Europe’s leading photovoltaic equipment supplier Meyer Burger, as it prepares for volume manufacturing. Meyer Burger was a co-lead investor in the Company’s recent Series D funding round.